Published in Bioinformatics on July 01, 2009
Memory T cells from minor histocompatibility antigen-vaccinated and virus-immune donors improve GVL and immune reconstitution. Blood (2011) 1.55
Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients. Bone Marrow Transplant (2012) 0.90
Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol (2016) 0.81
Making the genomic leap in HCT: application of second-generation sequencing to clinical advances in hematopoietic cell transplantation. Eur J Hum Genet (2013) 0.75
Stem-cell gene therapy for the Wiskott-Aldrich syndrome. N Engl J Med (2010) 3.09
Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol (2010) 2.71
Text mining: powering the database revolution. Nature (2007) 1.74
The nature of diversity and diversification at the ABO locus. Blood (2003) 1.51
Regulating MHC expression for cellular therapeutics. Transfusion (2007) 1.48
CMV-, EBV- and ADV-specific T cell immunity: screening and monitoring of potential third-party donors to improve post-transplantation outcome. Biol Blood Marrow Transplant (2013) 1.05
Heat shock protein 70 (HSP70) induces cytotoxicity of T-helper cells. Blood (2008) 1.05
The influence of semen-derived enhancer of virus infection on the efficiency of retroviral gene transfer. J Gene Med (2010) 1.05
Nondeletional ABO*O alleles frequently cause blood donor typing problems. Transfusion (2005) 1.03
Scoring HLA class I mismatches by HistoCheck does not predict clinical outcome in unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant (2011) 1.00
Development of a single-antigen magnetic bead assay (SAMBA) for the sensitive detection of HPA-1a alloantibodies using tag-engineered recombinant soluble β3 integrin. J Immunol Methods (2013) 0.98
Weak blood group B phenotypes may be caused by variations in the CCAAT-binding factor/NF-Y enhancer region of the ABO gene. Transfusion (2007) 0.95
Class-, gene-, and group-specific HLA silencing by lentiviral shRNA delivery. J Mol Med (Berl) (2006) 0.95
Impaired functionality of antiviral T cells in G-CSF mobilized stem cell donors: implications for the selection of CTL donor. PLoS One (2013) 0.94
The endogenous danger signals HSP70 and MICA cooperate in the activation of cytotoxic effector functions of NK cells. J Cell Mol Med (2010) 0.94
Tissue typing for hematopoietic cell transplantation: HLA-DQB1 typing should be included. Pediatr Transplant (2006) 0.93
The impact of human leukocyte antigen (HLA) micropolymorphism on ligand specificity within the HLA-B*41 allotypic family. Haematologica (2010) 0.93
MaHCO: an ontology of the major histocompatibility complex for immunoinformatic applications and text mining. Bioinformatics (2009) 0.90
Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry. Front Immunol (2013) 0.90
Evidence for a pathogenetic role of interleukin-18 in cutaneous lupus erythematosus. Arthritis Rheum (2008) 0.90
Influence of HLA alleles on shedding of Kaposi sarcoma-associated herpesvirus in saliva in an African population. J Infect Dis (2007) 0.90
A modular concept of HLA for comprehensive peptide binding prediction. Immunogenetics (2006) 0.89
HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells. PLoS One (2012) 0.89
HLA-universal platelet transfusions prevent platelet refractoriness in a mouse model. Hum Gene Ther (2013) 0.88
Permanent silencing of NKG2A expression for cell-based therapeutics. J Mol Med (Berl) (2008) 0.88
Short-term in-vitro expansion improves monitoring and allows affordable generation of virus-specific T-cells against several viruses for a broad clinical application. PLoS One (2013) 0.86
A general change of the platelet transfusion policy from apheresis platelet concentrates to pooled platelet concentrates is associated with a sharp increase in donor exposure and infection rates. Transfus Med Hemother (2008) 0.85
A single amino-acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared with HLA-A*6601 ligands. Immunogenetics (2004) 0.85
Induced pluripotent stem cells generated from adult bone marrow-derived cells of the nonhuman primate (Callithrix jacchus) using a novel quad-cistronic and excisable lentiviral vector. Cell Reprogram (2012) 0.84
Position 156 influences the peptide repertoire and tapasin dependency of human leukocyte antigen B*44 allotypes. Haematologica (2011) 0.84
ABO glycosyltransferases as potential source of minor histocompatibility antigens in allogeneic peripheral blood progenitor cell transplantation. Transfusion (2005) 0.84
The molecular diversity of Sema7A, the semaphorin that carries the JMH blood group antigens. Transfusion (2007) 0.84
The T/NK cell co-stimulatory molecule SECTM1 is an IFN "early response gene" that is negatively regulated by LPS in human monocytic cells. Biochim Biophys Acta (2011) 0.83
Generation of HLA-deficient platelets from hematopoietic progenitor cells. Transfusion (2010) 0.82
Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy. Hum Gene Ther Methods (2012) 0.82
Implementing the modular MHC model for predicting peptide binding. Methods Mol Biol (2007) 0.82
Semaphorin 3A alters endothelial cell immunogenicity by regulating Class II transactivator activity circuits. Transfusion (2014) 0.82
Amino acid 95 causes strong alteration of peptide position Pomega in HLA-B*41 variants. Immunogenetics (2007) 0.82
A dose-response analysis of lenograstim plus dexamethasone for neutrophil mobilization and collection. Transfusion (2005) 0.82
Secreted semaphorin 5A activates immune effector cells and is a biomarker for rheumatoid arthritis. Arthritis Rheumatol (2014) 0.81
Residue 81 confers a restricted C-terminal peptide binding motif in HLA-B*44:09. Immunogenetics (2012) 0.81
Granulocyte-colony-stimulatory factor: a strong inhibitor of natural killer cell function. Transfusion (2010) 0.81
Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice. Hum Gene Ther (2011) 0.81
Integrase-defective lentiviral vectors encoding cytokines induce differentiation of human dendritic cells and stimulate multivalent immune responses in vitro and in vivo. Vaccine (2012) 0.81
Easy identification of antibodies to high-prevalence Scianna antigens and detection of admixed alloantibodies using soluble recombinant Scianna protein. Transfusion (2009) 0.80
Position 45 influences the peptide binding motif of HLA-B*44:08. Immunogenetics (2011) 0.80
Heat shock protein 70/peptide complexes: potent mediators for the generation of antiviral T cells particularly with regard to low precursor frequencies. J Transl Med (2011) 0.80
Human primary keratinocytes show restricted ability to up-regulate suppressor of cytokine signaling (SOCS)3 protein compared with autologous macrophages. J Biol Chem (2012) 0.80
Colonization of collagen scaffolds by adipocytes derived from mesenchymal stem cells of the common marmoset monkey. Biochem Biophys Res Commun (2011) 0.80
A weak blood group A phenotype caused by a translation-initiator mutation in the ABO gene. Transfusion (2006) 0.80
IL-2 upregulates CD86 expression on human CD4(+) and CD8(+) T cells. J Immunol (2012) 0.79
PECAM-1-dependent heme oxygenase-1 regulation via an Nrf2-mediated pathway in endothelial cells. Thromb Haemost (2014) 0.79
Dysregulation of cell cycle control caused by overexpression of the oncogene pp32r1 (ANP32C) and the Tyr>His mutant pp32r1Y140H. Biochim Biophys Acta (2013) 0.79
Severe combined immunodeficiency-repopulating cell assay may overestimate long-term repopulation ability. Stem Cells (2007) 0.79
Rapid detection of anti-Lu(b) with recombinant Lu(b) protein and the particle gel immunoassay. Transfusion (2008) 0.79
Prokaryotic versus eukaryotic recombinant Lutheran blood group protein for antibody identification. Transfusion (2007) 0.79
Rapid detection of JMH antibodies with recombinant Sema7A (CD108) protein and the particle gel immunoassay. Transfusion (2008) 0.79
Monitoring dendritic cell and cytokine biomarkers during remission prior to relapse in patients with FLT3-ITD acute myeloid leukemia. Ann Hematol (2013) 0.79
HLA polymorphisms and detection of kaposi sarcoma-associated herpesvirus DNA in saliva and peripheral blood among children and their mothers in the uganda sickle cell anemia KSHV Study. Infect Agent Cancer (2010) 0.79
Growth characteristics of the nonhuman primate embryonic stem cell line cjes001 depending on feeder cell treatment. Cloning Stem Cells (2009) 0.78
Improved lentiviral gene transfer into human embryonic stem cells grown in co-culture with murine feeder and stroma cells. Biol Chem (2011) 0.78
Modulation of basophil activity: a novel function of the neuropeptide α-melanocyte-stimulating hormone. J Allergy Clin Immunol (2011) 0.78
Aberrant intracellular trafficking of a variant B glycosyltransferase. Transfusion (2008) 0.78
Mismatches outside exons 2 and 3 do not alter the peptide motif of the allele group B*44:02P. Hum Immunol (2011) 0.78
Expansion of human cytomegalovirus-specific T lymphocytes from unfractionated peripheral blood mononuclear cells with artificial antigen-presenting cells. Transfusion (2007) 0.77
Semaphorin 7A protein variants differentially regulate T-cell activity. Transfusion (2012) 0.77
Missense mutations outside the catalytic domain of the ABO glycosyltransferase can cause weak blood group A and B phenotypes. Transfusion (2005) 0.77
A weak blood group A phenotype caused by a new mutation at the ABO locus. Transfusion (2002) 0.77
Non-expression of HLA-A*2901102 N is caused by a nucleotide exchange in the mRNA splicing site at the beginning of intron 4. Tissue Antigens (2002) 0.77
Loss of single HLA class I allospecificities in melanoma cells due to selective genomic abbreviations. Int J Cancer (2002) 0.77
Tetanus toxoid provides efficient T-cell help for the induction of HA-1(H) cytotoxic T cells. Transfusion (2006) 0.77
Systematic analysis of the ABO gene diversity within exons 6 and 7 by PCR screening reveals new ABO alleles. Transfusion (2003) 0.77
Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8(+) T lymphocytes. Int Immunol (2012) 0.77
Soluble recombinant CMVpp65 spanning multiple HLA alleles for reconstitution of antiviral CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation. J Immunother (2010) 0.77
Discrimination of HLA null and low expression alleles by cytokine-induced secretion of recombinant soluble HLA. Mol Immunol (2009) 0.77
HistoCheck. Evaluating structural and functional MHC similarities. Methods Mol Biol (2007) 0.77